Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy
Anticancer Research · 2024
DOI: 10.21873/anticanres.17122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Noriyuki Ebi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ipilimumab, Nivolumab. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.
- Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan hinoue@fukuoka-u.ac.jp.
Zitieren
APA
Ebi, N., Inoue, H., Igata, F., Okuma, R., Kinoshita, E., Kawabata, T., Tan, I., Osaki, Y., Ikeda, T., Nakao, A., Shundo, Y., Hamada, N., & Fujita, M. (2024). Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy. Anticancer Research. https://doi.org/10.21873/anticanres.17122
Vancouver
Ebi N, Inoue H, Igata F, Okuma R, Kinoshita E, Kawabata T, et al. Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy. Anticancer Research. 2024. doi:10.21873/anticanres.17122
BibTeX
@article{Ebi2024,
author = {Ebi, Noriyuki and Inoue, Hiroyuki and Igata, Fumiyasu and Okuma, Rei and Kinoshita, Eriko and Kawabata, Toshiaki and Tan, Ibun and Osaki, Yusuke and Ikeda, Takato and Nakao, Akira and Shundo, Yuki and Hamada, Naoki and Fujita, Masaki},
title = {Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17122}
}
EUVIMED